Login
Sign Up
Search markets and profiles
Activity
Get Started
When will the FDA approve Intellia Therapeutics' lonvo-z? — Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema
$0 volume
Before 2028
60.0%
$0.60
Before October 2027
50.0%
$0.50
Before July 2027
36.0%
$0.36
1h
6h
24h
7d
1M
all
Loading chart...
Kalshi
Best value
$321 Vol
$0.60
Selected Bet
Before 2028
Trading via
Kalshi
Yes
$321 Vol
60.0%
No
$321 Vol
32.0%
Rules
Trade
Comments
Whales
Positions
Activity
Volume
No whale trades found for this event.
Trading via Kalshi
